InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (31 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
31
T+90 hit rate
0%
T+90 mean return
-16.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Heyman Richard A., Director. Insider active across 4 companies, notably Enliven Therapeutics, Inc.. In total, 35 filings have been recorded. Split: 0 buy · 31 sells. Total volume traded: €817k. History available since 11 May 2021. The latest transaction was disclosed on 6 July 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations35 total
300 shares@ US$12.00Common StockSEC:0001584759-26-000012:0
1,620 shares@ US$25.0050.0% of flowCommon StockSEC:0001584759-26-000004
1,620 shares@ US$25.000.0014% mcap50.0% of flowCommon StockSEC:0001584759-26-000004:0
817 shares@ US$30.0034.1% of flowCommon StockSEC:0001415889-24-025500:0
1,270 shares@ US$27.67195.9% of flowCommon StockSEC:0001415889-24-025381:0
2,825 shares@ US$27.505712.8% of flowCommon StockSEC:0001415889-24-024899:0
518 shares@ US$27.53732.3% of flowCommon StockSEC:0001415889-24-024668:0
1,270 shares@ US$22.4084.7% of flowCommon StockSEC:0001415889-24-023610:0
650 shares@ US$22.81622.5% of flowCommon StockSEC:0001415889-24-021644:0
1,702 shares@ US$27.50597.9% of flowCommon StockSEC:0001415889-24-020685:0
1,270 shares@ US$24.80065.3% of flowCommon StockSEC:0001415889-24-019731:0
1,270 shares@ US$21.47874.6% of flowCommon StockSEC:0001415889-24-017715:0
1,270 shares@ US$23.73995.0% of flowCommon StockSEC:0001415889-24-013833:0
5,045 shares@ US$25.030621.4% of flowCommon StockSEC:0001415889-24-010825:0
1,270 shares@ US$14.50293.1% of flowCommon StockSEC:0001415889-24-008883:0
367,446 shares@ US$62.50100.0% of flowCommon StockSEC:0001415889-24-005525:0
1,270 shares@ US$17.41533.7% of flowCommon StockSEC:0001415889-24-004495:0
1,270 shares@ US$16.40913.5% of flowCommon StockSEC:0001415889-24-002220:0
7 shares@ US$13.000.0% of flowCommon StockSEC:0001209191-23-059715:0
255 shares@ US$13.000.6% of flowCommon StockSEC:0001209191-23-059431:0
149,820 sharesCommon StockSEC:0001209191-23-013522:0
706 shares@ US$25.05110.0018% mcap5.7% of flowCommon StockSEC:0001209191-21-056461:0
706 shares@ US$25.05115.7% of flowCommon StockSEC:0001209191-21-056461
479 shares@ US$25.10050.0012% mcap3.9% of flowCommon StockSEC:0001209191-21-055871:0
479 shares@ US$25.10053.9% of flowCommon StockSEC:0001209191-21-055871
25 of 35 declarations
About Heyman Richard A.
Richard A. Heyman is a director at Enliven Therapeutics, Inc.
